Telix Pharmaceuticals Ltd (STU:T3X)
€ 14.31 -0.3 (-2.05%) Market Cap: 4.89 Bil Enterprise Value: 4.84 Bil PE Ratio: 162.08 PB Ratio: 19.98 GF Score: 75/100

Telix Pharmaceuticals Ltd Annual Shareholders Meeting Transcript

May 24, 2023 / 01:00AM GMT
Harry Kevin McCann
Telix Pharmaceuticals Limited - Independent Non-Executive Chairman

Well, good morning, and welcome shareholders and colleagues. It's 11:00. I'm Kevin McCann, Chairman of Telix Pharmaceuticals Limited, and I will be chairing this Annual General Meeting today.

On behalf of the Board of Directors, I'm delighted to welcome you to the company's sixth Annual General Meeting. It's sort of hard to believe we've reached a 6-year age, which is -- seems to have gone very quickly. Last year, we hosted a hybrid AGM to enable as many shareholders as possible to participate in this event. And it was -- we were able to get a large number of people throughout Australia joining us and also people from overseas.

Before we go to the formal business, I'd like to acknowledge the traditional custodians of country throughout Australia and their connections to land, sea and community. We pay our respects to their elders past and present and extend that respect to any indigenous and Torres Strait Islander peoples joining the meeting physically or virtually today.

Could I ask anyone

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot